Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California Institute for Regenerative Medicine
For Researchers
FUNDING OPPORTUNITIES
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
GRANTS
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
CLINICAL RESOURCES
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
RESEARCH RESOURCES
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Leadership
Our History
2023 Annual Report
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report Archive
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
All CIRM Grants
Search Filters »
Disease Focus
(All)
aa Multiple Diseases (Centers & Resoures) (14)
Age-related macular degeneration (10)
Aging (21)
Alpha Thalassemia Major (3)
Alzheimer's Disease (35)
Amyotrophic Lateral Sclerosis (56)
Anemia (10)
Angelman Syndrome (1)
Arthritis (14)
Autism (22)
B cell cancers (12)
Beta Thalassemia (5)
Bladder or Urinary Tract Disorder (6)
Blood Cancer (70)
Blood Disorders (106)
Bone Marrow Transplant and Viral Infection (5)
Bone or Cartilage Disease (49)
Brain Cancer (30)
Brain Injury, hypoxic, ischemic (2)
Breast Cancer (7)
Canavan Disease (1)
Cancer (151)
Cartilage defect (4)
Colon Cancer (6)
Corneal Damage (7)
COVID-19 (23)
Cystic Fibrosis (2)
Cystinosis (3)
Danon Disease (1)
Dementia (4)
Developmental Disorders (18)
Diabetes (50)
Diabetic Wounds (1)
Duchenne Muscular Dystrophy (3)
Epidermolysis Bullosa (3)
Epilepsy (10)
Fertility (13)
Genetic Disorder (36)
Hearing Loss (11)
Heart Disease (100)
Heart disease associated with Duchenne muscular dystrophy (2)
Heart failure (10)
Hemophilia A (2)
HIV-related Lymphoma (2)
HIV/AIDS (42)
Huntington's Disease (36)
Hyper IgM Syndrome (2)
Hypertension, pulmonary arterial (1)
Immune Disease (53)
Incontinence (2)
Infectious Disease (53)
Inflammatory bowel disease (1)
Intellectual Disability (4)
Intervertebral disc degeneration (2)
Intestinal Disease (16)
IPEX Syndrome (5)
Kidney Disease (15)
Kidney Failure (14)
Leukemia (10)
Leukemia, Acute Myeloid (AML) (20)
Leukocyte Adhesion Deficiency (2)
Liver Disease (22)
Lung Cancer (6)
Lung Disease, Fibrosis (5)
Melanoma (11)
Metabolic Disorders (81)
Multiple Myeloma (7)
Multiple Sclerosis (9)
Muscle Injury (3)
Muscular Dystrophy (23)
N/A (441)
Neurological Disorders (285)
Neuropathy (5)
Osteoarthritis (6)
Osteonecrosis (3)
Other (15)
Ovarian Cancer (7)
Pancreatic Cancer (3)
Parkinson's Disease (48)
Pediatrics (69)
Prostate Cancer (7)
Pulmonary Hypertension (3)
Respiratory Disorders (26)
Retinitis Pigmentosa (11)
Rett's Syndrome (7)
Sanfilippo Syndrome/MPS III (2)
Sarcoma (3)
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) (4)
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) (4)
Severe Combined Immunodeficiency, X-linked (X-SCID) (8)
Sickle Cell Disease (22)
Skeletal/Smooth Muscle disorders (41)
Skin cancer (2)
Skin Disease (17)
Solid Tumors (80)
Spina Bifida (4)
Spinal Cord Injury (40)
Spinal Muscular Atrophy (9)
Stroke (29)
Tendon/Ligament/Connective Tissue Injury or Disorder (2)
Thymic Disorder, 22q11 Deletion/DiGeorge (1)
Toxicity (7)
Trauma (11)
Traumatic Brain Injury (5)
Type 1 diabetes (20)
Vascular Disease (15)
Vision Loss (63)
Wounds, ulcers (1)
X-linked Chronic Granulomatous Disease (3)
Zika virus (2)
Institution
(All)
AcuraStem Inc. (1)
Adverum Biotechnologies (1)
Ali Nsair (1)
Alliance Forum Foundation (4)
American Association of Blood Banks (2)
Angiocrine Bioscience, Inc. (4)
Ankasa Regenerative Therapeutics, Inc. (2)
Aspen Neuroscience (1)
Aspera Biomedicines, Inc. (1)
Benjamin D. Yu (1)
Berkeley City College (2)
Biocom Institute (1)
BioEclipse Therapeutics INC. (1)
Biomedical Engineering Society (1)
BioTime, Inc. (1)
Bluebird Bio (1)
Boston Children’s Hospital (1)
Brain Mapping Foundation (1)
Brain Neurotherapy Bio (1)
BrainStorm Cell Therapeutics (1)
BrainXell Therapeutics (2)
Buck Institute for Age Research (9)
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo (4)
Cal Poly Pomona Foundation (1)
Cal State Univ, Fullerton (4)
Cal State Univ, Long Beach (3)
Cal State Univ, Sacramento (3)
Cal State Univ, San Bernadino (4)
Caladrius Biosciences (2)
Calibr (3)
Calidi Biotherapeutics, Inc. (1)
California Institute of Technology (5)
California State University San Marcos Corporation (7)
California State University, Channel Islands (3)
Calimmune, Inc. (1)
Capricor, Inc (2)
Cedars-Sinai Medical Center (41)
Cellerant Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Cellular Dynamics International (1)
Celularity Inc. (1)
Chardan (1)
Charles R. Drew University of Medicine and Science (1)
Children’s Hospital of Los Angeles (17)
Children’s Hospital of Orange County (2)
Children’s Neurobiological Solutions (CNS) Foundation (1)
City College Of San Francisco (3)
City of Hope, Beckman Research Institute (54)
Combangio, Inc. (1)
Cytonus Therapeutics, Inc. (1)
Defined Bioscience, Inc. (1)
Elpida Therapeutics (1)
Escape Therapeutics, Inc (1)
Eureka Therapeutics, Inc. (1)
ExCellThera Inc. (1)
Excision BioTherapeutics (1)
Fate Therapeutics, Inc. (1)
Fluidigm Corporation (2)
Forty Seven Inc. (2)
FUJIFILM Cellular Dynamics (1)
Gamma Medica-Ideas, Inc. (1)
Genascence Corporation (1)
Geron Corporation (2)
Gladstone Institutes, J. David (37)
Global Genes (1)
GMR Epigenetics (1)
Gordon Research Conferences (3)
Greenstone Biosciences, Inc. (3)
HEALIOS NA, Inc. (1)
Humacyte, Inc. (2)
Human BioMolecular Research Institute (4)
Human Organ Project (1)
Humboldt State University Sponsored Programs Foundation (3)
Immune-Onc Therapeutics (1)
ImmunoCellular Therapeutics (1)
ImmunoVec (3)
Immusoft Corporation (2)
Int. Soc. for Cell Gene Ther. (1)
Intact Therapeutics, Inc. (1)
International Alliance for Biological Standardization (1)
International Society for Experimental Hematology (1)
International Society for Stem Cell Research (6)
International Symposium on Neural Regeneration, Inc. (1)
iPierian, Inc. (2)
IQVIA, Inc. (2)
Jackson Labs (1)
Jasper Therapeutics, Inc. (1)
jCyte, Inc (2)
JDRF International (2)
Juvena Therapeutics Inc. (1)
Keystone Symposia on Molecular and Cellular Biology (3)
La Jolla Institute for Allergy and Immunology (1)
Lineage Cell Therapeutics, Inc. (2)
Loma Linda University (2)
Ludwig Institute for Cancer Research (3)
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center (3)
Mahzi Therapeutics (1)
MAX BioPharma, Inc. (1)
Medeor Therapeutics, Inc. (1)
Midwinter Conference of Immunologists (3)
Minutia, Inc. (1)
MiraCosta College (1)
Mohammad Pashmforoush (1)
Mosaic Event Management, Inc. (1)
MyoGene Bio LLC (1)
Nammi Therapeutics, Inc. (1)
Nanotools Bioscience (1)
Navega Therapeutics (1)
Neurona Therapeutics (4)
Nohla Therapeutics Inc (1)
Novoglia, Inc. (1)
Numerate, Inc. (1)
OCTANe Foundation for Innovation (1)
Ocular Research Symposia Foundation, Inc. (1)
OncoMed Pharmaceuticals, Inc. (1)
Orchard Therapeutics plc (1)
Organos, Inc. (1)
Ossium Health, Inc. (1)
Palo Alto Veterans Institute for Research (6)
Parkinson’s Institute (5)
Pasadena City College (3)
Pathways to Stem Cell Science (1)
Poseida Therapeutics, Inc. (2)
Rampart Bioscience (1)
RARE-X (1)
Ray Therapeutics, INC (2)
Regencor, Inc. (1)
Regenerative Patch Technologies LLC (1)
Rejuvenation Technologies, Inc. (1)
Research for Cure (1)
Reza Ardehali (1)
Rocket Pharmaceuticals, Inc. (2)
Rubedo Life Sciences Inc. (1)
Rumi Scientific CA (1)
RUNX1 Research Program (1)
Ryne Biotechnology (1)
Salk Institute for Biological Studies (23)
Samumed, LLC (1)
San Diego State University Foundation (5)
San Francisco State University (4)
SanBio, Inc. (1)
Sanford Burnham Prebys Medical Discovery Institute (27)
Sanford Consortium for Regenerative Medicine (8)
Sangamo BioSciences, Inc. (2)
Scaled Biolabs Inc. (1)
Scripps Health (5)
Scripps Research Institute (29)
Semma Therapeutics (1)
Siren Biotechnology, Inc. (1)
SJSU Research Foundation (3)
Solano Community College (1)
St. Jude Children’s Research Hospital (1)
Stanford University (172)
StemCells, Inc. (3)
Summit for Stem Cell Foundation (1)
Tachyon Therapeutics, Inc (1)
Tenaya Therapeutics, Inc. (1)
The American Society of Gene & Cell Therapy (1)
The Biomedical Engineering Society (1)
The Regents of the University of California on behalf of its Riverside Campus (9)
The Scintillon Institute (2)
The Stone Research Foundation for Sports Medicine and Arthritis (1)
The University Corporation at California State University, Northridge (4)
Tippi C. Mackenzie (1)
TriFoil Imaging, Inc. (1)
UCSF Benioff Children’s Hospital Oakland (8)
University of California, Berkeley (33)
University of California, Davis (76)
University of California, Irvine (69)
University of California, Los Angeles (156)
University of California, Merced (7)
University of California, San Diego (133)
University of California, San Francisco (119)
University of California, Santa Barbara (13)
University of California, Santa Cruz (16)
University of Southern California (52)
Vala Sciences, Inc. (1)
Vertuis Bio, Inc. (1)
ViaCyte, Inc. (9)
VistaGen Therapeutics, Inc. (1)
Vitabolus, Inc. (1)
Vitalant Research Institute (6)
VxBiosciences inc. (1)
Wake Forest University Health Sciences (1)
Western University of Health Sciences (1)
X-Therma Inc. (1)
Zenobia Therapeutics (1)
Program Type
(All)
Clinical (149)
Discovery (707)
Education (306)
Infrastructure (92)
Translation (146)
Grant Type
(All)
Accelerated Development Pathway I (1)
Accelerating Center (1)
Alpha Stem Cell Clinics (3)
Alpha Stem Cell Clinics Network Expansion (12)
Basic Biology I (12)
Basic Biology II (16)
Basic Biology III (27)
Basic Biology IV (28)
Basic Biology V (28)
Bridges (16)
Bridges (29)
Clinical Trial Stage Projects (3)
Clinical Trial Stage Projects (79)
COMPASS Training Grant (16)
Comprehensive Grant (29)
Conference (81)
Conference – Lung Regenerative Medicine Workshop (1)
Conference – Manage a Symposium on Pluripotent Stem Cell Manufacturing (1)
Conference – Manage The 2016 Bridges And SPARK Annual Meetings (1)
Conference – Manage The Bridges Annual Meeting (4)
Conference – Manage The SPARK Annual Meeting (6)
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The Alpha Stem Cell Clinic Annual Symposium (2)
Conference – The 2020 Grantee Meeting (1)
Conference II (65)
Creativity Awards (9)
Cure Sickle Cell Initiative Clinical Trial Stage Projects (3)
Diagnostic Translational Research Projects (2)
Discovery Research Projects (12)
Discovery Research Projects (1)
Disease Team Planning (22)
Disease Team Research I (15)
Disease Team Therapy Development – Research (12)
Disease Team Therapy Development III (6)
Disease Team Therapy Planning I (19)
Early Translational from Disease Team Conversion (3)
Early Translational I (16)
Early Translational II (24)
Early Translational III (21)
Early Translational IV (14)
Foundation – Discovery Stage Research Projects (28)
Genomics Centers of Excellence Awards (R) (3)
hiPSC Derivation (1)
hPSC Repository (1)
Inception – Discovery Stage Research Projects (39)
iPSC Consortia Award (1)
Late Stage Preclinical Projects (39)
Major Facilities (12)
Manufacturing Network Grant (9)
Medical Device Translational Research Projects (1)
New Cell Lines (18)
New Faculty I (26)
New Faculty II (24)
New Faculty Physician Scientist (15)
Patent Assistance Fund Awards (8)
Preclinical Development Awards (7)
Progression Award – Discovery Stage Research Projects (8)
Quest – Discovery Stage Research Projects (144)
Research Leadership (14)
Research Training Grant (18)
Research Training II (17)
SEED Grant (74)
Shared Labs (34)
SPARK (18)
Strategic Partnership I (2)
Strategic Partnership II (1)
Strategic Partnership III Track A (2)
Targeted Clinical Development (1)
Therapeutic Translational Research Projects (73)
Therapeutic Translational Research Projects (1)
Tissue Collection for Disease Modeling (7)
Tool Translational Research Projects (6)
Tools and Technologies I (23)
Tools and Technologies II (20)
Tools and Technologies III (22)
Training Grant I-1 (8)
Training Grant I-2 (5)
Training Grant I-3 (3)
Translating Center (1)
Transplantation Immunology (20)
Human Stem Cell Use
(All)
Adult or Tissue Stem Cell (299)
Cancer Stem Cell (43)
Directly Reprogrammed Cell (11)
Embryonic Stem Cell (383)
iPS Cell (287)
N/A (405)
Other (11)
SCNT (2)
Somatic Cell (19)
Vital Research Opportunity (3)
Cell Line Generation
(All)
Adult or Tissue Stem Cell (60)
Cancer Stem Cell (12)
Directly Reprogrammed Cell (2)
Embryonic Stem Cell (52)
iPS Cell (126)
N/A (1048)
Other (9)
SCNT (2)
Collaborative Funder
(All)
Andalusia, Spain (1)
Australia (3)
Canada (2)
France (1)
Germany (10)
Japan (1)
NIH (3)
United Kingdom (3)
Victoria, Australia (6)
Award Status
(All)
Active (292)
Closed (1076)
Pre-Active (32)
Institution
Researcher name
Grant Type
Grant Title
Award Value
University of California, San Francisco
Dr. Robert Blelloch Dr.
SEED Grant
MicroRNA Regulation of Human Embryonic Stem Cell Self-Renewal and Differentiation
$605,886
Sanford Burnham Prebys Medical Discovery Institute
Dr. Hudson Freeze
SEED Grant
Role of Glycans in Human Embryonic Stem Cell Conversion to Neural Precursor Cells
$708,000
University of California, San Diego
Dr Sylvia Evans
SEED Grant
Specification of Ventricular Myocyte and Pacemaker Lineages Utilizing Human Embryonic Stem Cells
$585,600
Salk Institute for Biological Studies
Dr. Beverly M Emerson Dr.
SEED Grant
Regulation of Specific Chromosomal Boundary Elements by CTCF Protein Complexes in Human Embryonic Stem Cells
$647,343
University of California, Santa Cruz
Dr. Bin Chen
SEED Grant
In vitro differentiation of hESCs into corticospinal motor neurons
$465,624
Human BioMolecular Research Institute
Dr. John R Cashman
SEED Grant
Discovering Potent Molecules with Human ESCs to Treat Heart Disease
$688,274
Buck Institute for Age Research
Dr. Dale E. Bredesen
SEED Grant
Programmed Cell Death Pathways Activated in Embryonic Stem Cells
$728,950
University of California, Los Angeles
Dr. Douglas L. Black
Basic Biology II
Programs of alternative splicing regulation by polypyrimidine tract binding protein
$1,344,562
University of California, San Diego
Dong-Er Zhang
Basic Biology II
RUNX1 in maintenance, expansion, and differentiation of therapeutic pluripotent stem cells
$1,371,540
University of California, Irvine
Professor Marian L Waterman
Basic Biology II
TCF-3: A Wnt Pathway Effector and Nanog Regulator in Pluripotent Stem Cell Self-Renewal
$1,259,879
iPierian, Inc.
Dr. Irene Griswold-Prenner
Basic Biology II
Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency
$1,458,000
Palo Alto Veterans Institute for Research
Dr. Tony Wyss-Coray
Basic Biology II
Systemic Protein Factors as Modulators of the Aging Neurogenic Niche
$1,159,806
Stanford University
Professor Garry P Nolan
Basic Biology II
Kinase signaling analysis of iPS cell reprogramming and differentiation
$1,343,100
University of California, Los Angeles
Dr. Benhur Lee
Basic Biology II
The EphrinB2/EphB4 axis in regulating hESC pluripotency and differentiation
$1,371,936
University of California, Davis
Dr. Eric A Kurzrock
Basic Biology II
Differentiation of Human Embryonic Stem Cells into Urothelium
$849,037
University of California, Los Angeles
Dr. Yong Kim
Basic Biology II
Novel Mechanism in Self-Renewal/Differentiation of Human Embryonic Stem Cells
$1,259,371
University of California, San Diego
Dr. Kun-Liang Guan
Basic Biology II
The function of YAP in human embryonic stem cells
$1,245,693
Stanford University
Dr. Aaron J Hsueh
Basic Biology II
Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation
$1,309,018
University of California, San Francisco
Dr. John L Rubenstein
Basic Biology II
MGE Enhancers to Select for Interneuron Precursors Produced from Human ES Cells
$1,387,800
Sanford Burnham Prebys Medical Discovery Institute
Dr. Huei-sheng Vincent Chen
Basic Biology II
Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes
$1,587,610
University of California, Irvine
Dr. Aileen J Anderson
Basic Biology II
Role of the microenvironment in human iPS and NSC fate and tumorigenesis
$1,256,194
Stanford University
Dr. Steven Edward Artandi
Basic Biology II
Self-renewal and senescence in iPS cells derived from patients with a stem cell disease
$931,285
Salk Institute for Biological Studies
Ronald Mark Evans
Basic Biology II
Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs
$1,712,880
Calimmune, Inc.
Geoff Symonds
Disease Team Research I
GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE
$8,278,722
Stanford University
Dr. Gary Steinberg
Disease Team Research I
Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke
$17,244,851
University of California, San Diego
Dr. Lawrence S. B. Goldstein
Disease Team Research I
Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis
$5,694,308
University of California, Los Angeles
Mr. Donald B. Kohn
Disease Team Research I
Stem Cell Gene Therapy for Sickle Cell Disease
$8,833,695
University of California, Los Angeles
Dr. Irvin SY Chen
Disease Team Research I
HPSC based therapy for HIV disease using RNAi to CCR5.
$9,905,604
ViaCyte, Inc.
Allan Robins
Disease Team Research I
Cell Therapy for Diabetes
$0
Cedars-Sinai Medical Center
Eduardo Marbán
Disease Team Research I
Autologous cardiac-derived cells for advanced ischemic cardiomyopathy
$5,560,232
University of California, San Francisco
Dr. Mitchel S Berger
Disease Team Research I
Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM)
$6,214,914
City of Hope, Beckman Research Institute
Prof. Karen S Aboody M.D.
Disease Team Research I
Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials
$17,890,623
Stanford University
Dr. Alfred T Lane
Disease Team Research I
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa
$11,039,208
Stanford University
Dr. Irving L Weissman MD
Disease Team Research I
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells
$18,759,276
University of California, Los Angeles
Dr. Dennis J Slamon
Disease Team Research I
Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors
$19,979,660
City of Hope, Beckman Research Institute
Prof. John A Zaia
Disease Team Research I
ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS
$14,536,969
University of Southern California
Dr. Mark S Humayun
Disease Team Research I
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD)
$18,904,916
University of California, San Diego
Dr. Dennis A Carson
Disease Team Research I
Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)
$19,999,826
University of California, San Diego
Gene Wei-Ming Yeo
Basic Biology I
RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency
$1,308,901
University of California, San Diego
Karl H. Willert
Basic Biology I
WNT signaling and the control of cell fate decisions in human pluripotent stem cells.
$1,329,298
University of California, Davis
Dr. Min Zhao
Basic Biology I
Directing migration of human stem cells with electric fields
$816,228
University of California, Los Angeles
Dr. Michael A. Teitell
Basic Biology I
Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer
$1,323,029
University of Southern California
Dr. Martin Pera
Basic Biology I
The stem cell microenvironment in the maintenance of pluripotency and reprogramming
$1,325,723
Stanford University
Dr. Julian Sage
Basic Biology I
The retinoblastoma (RB) gene family in cellular reprogramming
$1,357,085
Stanford University
Dr. Susan K McConnell
Basic Biology I
Identification and characterization of human ES-derived DA neuronal subtypes
$1,404,853
University of California, Los Angeles
Dr. Bennett G Novitch Ph.D.
Basic Biology I
Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons
$1,228,278
University of California, Los Angeles
Dr. Robb Maclellan Dr.
Basic Biology I
Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate
$917,667
University of Southern California
Dr. Wange Lu
Basic Biology I
Defining the molecular mechanisms of somatic cell reprogramming
$1,365,580
Stanford University
Dr. Helen M Blau
Basic Biology I
Molecular Mechanisms of Reprogramming towards Pluripotency
$1,408,332
University of California, Los Angeles
Dr. Luisa Iruela-Arispe
Basic Biology I
Molecular Characterization and Functional Exploration of Hemogenic Endothelium
$1,371,477
« Previous
1
…
18
19
20
21
22
23
24
25
26
27
28